Integrated lipidomics and transcriptomic analysis of peripheral blood reveals significantly enriched pathways in type 2 diabetes mellitus

BMC Medical Genomics

Volumn 6, Issue SUPPL.1, 2013, Pages

  Wang, Yunliang ^f   Zhao, Chen ^a,b   Mao, Jinghe ^c   Ai, Junmei ^d   Shenwu, Ming ^c   Shi, Tieliu ^b   Zhang, Daqing ^e   Wang, Xiaonan ^a   Deng, Youping ^a  

^a WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c TOUGALOO COLLEGE   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

^e SOOCHOW UNIVERSITY   (China)

^f The 148 Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSUGAR; ARACHIDONIC ACID; CYSTEINE; FOLIC ACID; GLUTAMIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOLEUCINE; LEUCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NUCLEOTIDE; PROLINE; PROPIONIC ACID; STARCH; SUCROSE; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD ANALYSIS; CARBOHYDRATE METABOLISM; CAUCASIAN; CHOLESTEROL BILE LEVEL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; LIPID ANALYSIS; LIPIDOMICS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 84872963322     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-S1-S12     Document Type: Article

References (19)

1. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Porte D Jr, Diabetes 1991 40 2 166 180 10.2337/diabetes.40.2.166 1991568
2. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Bergman RN, Diabetes 1989 38 12 1512 1527 10.2337/diabetes.38.12.1512 2684710 (Pubitemid 20006675)
3. Disordered lipid metabolism and the pathogenesis of insulin resistance. Savage DB, Petersen KF, Shulman GI, Physiological reviews 2007 87 2 507 520 10.1152/physrev.00024.2006 17429039 (Pubitemid 47084679)
4. Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Frederiksen CM, Hojlund K, Hansen L, Oakeley EJ, Hemmings B, Abdallah BM, Brusgaard K, Beck-Nielsen H, Gaster M, Diabetologia 2008 51 11 2068 2077 10.1007/s00125-008-1122-9 18719883
5. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Yazaki Y, et al. Diabetes 1999 48 7 1365 1371 10.2337/diabetes.48.7.1365 10389840 (Pubitemid 29297297)
6. Type 2 diabetes mellitus-induced hyperglycemia in patients with NAFLD and normal LFTs: relationship to lipid profile, oxidative stress and pro-inflammatory cytokines. Shams ME, Al-Gayyar MM, Barakat EA, Scientia pharmaceutica 2011 79 3 623 634 10.3797/scipharm.1104-21 21886908
7. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K, Diabetes 2003 52 10 2461 2474 10.2337/diabetes.52.10.2461 14514628 (Pubitemid 37210533)
8. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Boden G, Shulman GI, European journal of clinical investigation 2002 32 Suppl 3 14 23 12028371 (Pubitemid 41704996)
9. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Bergman RN, Ader M, Trends in endocrinology and metabolism: TEM 2000 11 9 351 356 10.1016/S1043-2760(00)00323-4 11042464
10. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. Bays H, Mandarino L, DeFronzo RA, The Journal of clinical endocrinology and metabolism 2004 89 2 463 478 10.1210/jc.2003-030723 14764748 (Pubitemid 38269844)
11. Gene expression profile in obesity and type 2 diabetes mellitus. Das UN, Rao AA, Lipids in health and disease 2007 6 35 10.1186/1476-511X-6-35 18078524 (Pubitemid 351248703)
12. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS, Diabetes 2002 51 6 1913 1920 10.2337/diabetes.51.6.1913 12031981 (Pubitemid 34564306)
13. Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics. Zhou X, Mao J, Ai J, Deng Y, Roth MR, Pound C, Henegar J, Welti R, Bigler SA, PLoS One 2012 7 11 48889 10.1371/journal.pone. 0048889 23152813
14. Analysis of common and specific mechanisms of liver function affected by nitrotoluene compounds. Deng Y, Meyer SA, Guan X, Escalon BL, Ai J, Wilbanks MS, Welti R, Garcia-Reyero N, Perkins EJ, PLoS One 2011 6 2 14662 10.1371/journal.pone.0014662 21346803
15. R: a language and environment for statistical computing. Team RDC, 2008
16. Using GOstats to test gene lists for GO term association. Falcon S, Gentleman R, Bioinformatics 2007 23 2 257 258 10.1093/bioinformatics/btl567 17098774 (Pubitemid 46189622)
17. CMA: synthesis of microarray-based classification. Slawski M, Boulesteix AL, Bernau C, 2009
18. Partial least squares and principal component regression. pls, 2011
19. The KEGG database. Kanehisa M, Novartis Foundation symposium 2002 247 91 101 discussion 101-103, 119-128, 244-152 12539951